Balance Sheet
Cash Flow Statement
AmortizationChange in TaxesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Capital Expenditures (2021 - 2022)

Historic Capital Expenditures for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $1.5 million.

  • ProQR Therapeutics' Capital Expenditures rose 66642.2% to $1.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $689557.4, marking a year-over-year increase of 22204.76%. This contributed to the annual value of $1.5 million for FY2024, which is 348.75% up from last year.
  • As of Q4 2022, ProQR Therapeutics' Capital Expenditures stood at $1.5 million, which was up 66642.2% from -$248035.5 recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Capital Expenditures registered a high of $1.5 million during Q4 2022, and its lowest value of -$273850.4 during Q1 2022.